Arbaclofen in fragile X syndrome: results of phase 3 trials

Overview of attention for article published in Journal of Neurodevelopmental Disorders, June 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#18 of 514)
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

So far, Dimensions has found 140 publications that cite this research output.

Article in FOCUS The Journal of Lifelong Learning in Psychiatry (April 2024)

Article in Expert Opinion on Pharmacotherapy (March 2024)

Preprint in bioRxiv (December 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.